Yokogawa Electric Acquires Fluid Imaging Technologies

Saint-Gobain Life Sciences Acquires Equflow B.V.

September 2, 2021

Medical Devices

Saint-Gobain Life Sciences has acquired Equflow B.V., a Netherlands-based designer and manufacturer of flowmeters and sensors serving the single-use bioprocessing market. The acquisition expands Saint-Gobain's Bio-Process Solutions product capabilities and single-use fluid management offerings.

Detection Technology Acquires Haobo Imaging

July 3, 2023

Medical Devices

Detection Technology Plc has completed the acquisition of 90% of Shanghai Haobo Imaging Technology Co., Ltd (Haobo Imaging) for EUR 12 million, financed with cash reserves and a term loan. Haobo, a Shanghai-based maker of TFT flat-panel X-ray detectors with ~40 employees, will be integrated into Detection Technology's Medical Business Unit while the founders and management retain 10% and the buyer intends to acquire the remainder under agreed terms.

Vessco Water Acquires Atlantic Fluid Technology

November 21, 2025

Industrial Services

Vessco Water announced that Atlantic Fluid Technology (Northborough, Massachusetts) has joined the Vessco Water platform as an add-on acquisition. The deal expands Vessco's presence in New England's municipal and industrial water and wastewater markets and adds engineering, distribution, and field-service capabilities focused on valves, actuators, control panels and flow-control equipment.

Rigaku Corporation Acquires MILabs B.V.

August 2, 2021

Medical Devices

Rigaku Corporation acquired all issued shares of MILabs B.V., a Netherlands-based manufacturer of preclinical PET, SPECT, CT and optical imaging systems, closing on August 2, 2021. The deal expands Rigaku's entry into the life sciences and pre-clinical imaging market by combining MILabs' multi-modality imaging capabilities with Rigaku's X-ray imaging and global sales and service network.

Illumina Acquires Fluent BioSciences

July 9, 2024

Biotechnology

Illumina, Inc. has acquired Fluent BioSciences to integrate Fluent's PIPseq single-cell technology into Illumina's product portfolio and accelerate its multiomics capabilities. The acquisition, which closed July 9, 2024 and was funded with cash on hand, brings Fluent's accessible, scalable single-cell chemistry and the Fluent team into Illumina to expand end-to-end single-cell solutions for research and applied customers.

Quanterix Corporation Acquires Akoya Biosciences

July 8, 2025

Medical Devices

Quanterix Corporation has completed its acquisition of Akoya Biosciences, combining Quanterix's ultra‑sensitive blood biomarker detection platform with Akoya's spatial biology imaging and reagents. Under the amended merger agreement, Quanterix issued approximately 7.8 million shares and paid about $20 million in cash to Akoya equity holders; the combined business is expected to expand the company's served addressable market and accelerate the path to profitability.